To say that Bill Linton has a long-term vision for Promega, the Fitchburg, WI-based biotech business he founded in 1978 and continues to lead as chairman and CEO, would qualify as an understatement. In 2013, he told the Isthmus newspaper that he was working to arrange a corporate structure that would allow Promega “to celebrate its 100-year anniversary as a private company, as an independent company.”
Linton’s commitment to organic growth—and avoidance of a merger or acquisition that could force the company to relocate—has been a boon to the state’s life sciences sector, and to the business community in general. A majority of the company’s 1,400 employees are based in Wisconsin, and over the years a number of Promega spinoffs have been launched, including Epicentre, Lucigen, and PanVera. Read the full story here.
;
